FDA Inspection
Quest Diagnostics Nichols InstituteQuest Diagnostics Nichols Institute – FDA Inspection, Sep 23, 2019
Record Details
This FDA Inspection record concerns Quest Diagnostics Nichols Institute, with an inspection on September 23, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · facad8ec-7964-4b97-a755-4fcccdd5b781
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1102830
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 1271.160(b)(1)Ensuring appropriate core requirements followed
- 21 CFR 1271.80(c)Manufacturer instructions not followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Quest Diagnostics Nichols Institute
7| Date | Classification | Office | Project area |
|---|---|---|---|
| May 15, 2025 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| August 30, 2021 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| January 12, 2017 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| March 26, 2015 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| June 19, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Quest Diagnostics Nichols Institute
- FDA Inspection 1270643 - 2025-05-15
- FDA Inspection 1150115 - 2021-08-30
- FDA Inspection 998528 - 2017-01-12
- FDA Inspection 919955 - 2015-03-26
- FDA Inspection 835530 - 2013-06-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.